Southeast Bone Marrow Transplant Consortium

The Southeast Bone Marrow Transplant Consortium (SEBMTC) is a non-profit collaborative network of academic medical centers dedicated to advancing the field of hematopoietic stem cell transplantation and cellular therapy. Established to foster cooperation among institutions in the Southeastern United States, the consortium coordinates multi-center clinical trials and develops standardized treatment protocols to improve patient outcomes. Its research primarily focuses on hematologic malignancies, including leukemia and lymphoma, as well as the management of transplant-related complications such as graft-versus-host disease. By pooling data and resources from its member hospitals, SEBMTC provides a robust infrastructure for clinical research and the implementation of innovative cell-based therapies. The organization plays a critical role in bridging the gap between laboratory discovery and clinical application within the regional healthcare ecosystem.